World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
19069
World Ranking
8536
National Ranking
293

Brian Leber publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Brian Leber sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 246 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Brian Leber D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Brian Leber sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 66 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Brian Leber is affiliated with McMaster University in Canada and has a research profile primarily rooted in the field of Medicine, with significant focus on Hematology, Genetics, and Molecular Biology. Their work spans several subfields including Oncology and Public Health, Environmental and Occupational Health.

Leber's research contributions often concentrate on leukemia and related hematologic conditions. Main topics in their body of work include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia Research
  • Histone Deacetylase Inhibitors Research
  • Neutropenia and Cancer Infections

Several recent papers illustrate the scope of Leber's research interests. Notable publications include:

  • "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia" (2020), published in New England Journal of Medicine
  • "Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia" (2024), published in American Journal of Hematology
  • "Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study" (2023), published in The Lancet Haematology
  • "Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial" (2021), published in Annals of Hematology
  • "The carboxyl-terminal sequence of bim enables bax activation and killing of unprimed cells" (2020), published in eLife

Frequent coauthors frequently collaborating with Leber include:

  • Karen Yee
  • Dina Khalaf
  • Mitchell Sabloff
  • Mary-Margaret Keating
  • Rena Buckstein

Leber has published multiple times in prominent venues related to hematology and oncology, notably:

  • Blood
  • Leukemia & lymphoma/Leukemia and lymphoma
  • British Journal of Haematology
  • Clinical Lymphoma Myeloma & Leukemia
  • Current Oncology

Best Publications

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

    Courtney D DiNardo;Brian A Jonas;Vinod Pullarkat;Michael J Thirman

  • Telomerase activity in normal leukocytes and in hematologic malignancies.

    Christopher M. Counter;Jyothi Gupta;Calvin B. Harley;Brian Leber

  • Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis

    Eric Daugas;Santos A. Susin;Naoufal Zamzami;Karine F. Ferri

  • Mechanisms of Action of Bcl-2 Family Proteins

    Aisha Shamas-Din;Justin Kale;Brian Leber;David W. Andrews

  • Membrane Binding by tBid Initiates an Ordered Series of Events Culminating in Membrane Permeabilization by Bax

    Jonathan F. Lovell;Lieven P. Billen;Scott Bindner;Aisha Shamas-Din

  • Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells

    Eleftherios Sachlos;Ruth M. Risueño;Sarah Laronde;Zoya Shapovalova

  • Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator.

    Catherine Brenner;Hervé Cadiou;Helena La Vieira;Naoufal Zamzami

  • BH3-only proteins: Orchestrators of apoptosis.

    Aisha Shamas-Din;Hetal Brahmbhatt;Brian Leber;David W. Andrews

  • Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes

    Brian Leber;Jialing Lin;David W. Andrews

  • Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis

    Matthew G Annis;Erinn L Soucie;Paulina J Dlugosz;Jorge A Cruz-Aguado

  • Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types.

    W Zhu;A Cowie;G W Wasfy;L Z Penn

  • Bcl-XL inhibits membrane permeabilization by competing with Bax.

    Lieven P Billen;Candis L Kokoski;Jonathan F Lovell;Brian Leber

  • Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

    Sarit Assouline;Biljana Culjkovic;Eftihia Cocolakis;Caroline Rousseau

  • Bcl-2 changes conformation to inhibit Bax oligomerization

    Paulina J Dlugosz;Lieven P Billen;Matthew G Annis;Weijia Zhu

  • Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

    D J DeAngelo;K E Stevenson;S E Dahlberg;L B Silverman

  • Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.

    Carolyn J. Owen;Carolyn J. Owen;Cynthia L. Toze;Anna Koochin;Donna L. Forrest

  • Interaction with a Membrane Surface Triggers a Reversible Conformational Change in Bax Normally Associated with Induction of Apoptosis

    Jeremy A. Yethon;Raquel F. Epand;Brian Leber;Richard M. Epand

  • Campath-1H Treatment of T-Cell Prolymphocytic Leukemia in Patients for Whom at Least One Prior Chemotherapy Regimen Has Failed

    M. J. Keating;B. Cazin;S. Coutré;R. Birhiray

  • Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis.

    Weijia Zhu;Brian Leber;David W. Andrews

  • Still embedded together binding to membranes regulates Bcl-2 protein interactions.

    B Leber;J Lin;D W Andrews

Frequent Co-Authors

David W. Andrews
David W. Andrews Sunnybrook Health Science Centre
Suzanne Kamel-Reid
Suzanne Kamel-Reid University Health Network
Mickie Bhatia
Mickie Bhatia McMaster University
Mark D. Minden
Mark D. Minden Princess Margaret Cancer Centre
Vikas Gupta
Vikas Gupta Princess Margaret Cancer Centre
Timothy P. Hughes
Timothy P. Hughes South Australian Health and Medical Research Institute
Francisco Cervantes
Francisco Cervantes University of Barcelona
Jorge E. Cortes
Jorge E. Cortes Augusta University
Kenneth Rockwood
Kenneth Rockwood Dalhousie University
Linda Z. Penn
Linda Z. Penn University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens diverse opportunities in healthcare, research, and industry. Online education options now make it easy to pursue advanced degrees and specialized careers. For those interested in nursing leadership roles, the msn to dnp online no clinicals programs allow you to earn a Doctor of Nursing Practice without the traditional clinical requirements.

If you are passionate about management within healthcare institutions, consider a phd in healthcare administration online. For those focused on pharmaceuticals, online pharmacy schools offer flexible paths to earning a pharmacy doctorate.

Additionally, if you are interested in human physiology, athletics, or wellness, the best online exercise science degree programs blend biology and practice for careers in sports science, physical therapy, or fitness consulting.

Exploring these related online degrees can help you tailor your education and advance in a field that aligns with your interests and long-term career goals.

Best Scientists Citing Brian Leber

Trending Scientists